Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life

Inclusion Criteria: * Male or female ≥ 75 years of age; * Type 2 diabetes for at least 1 year and treated with insulin for at least 6 months; * Treated with basal insulin (ie glargine U100: Lantus®, Abasaglar®, glargine U300: Toujeo®, detemir: levemir®, NPH), premix (ie Novomix® and Humalog Mix®), and / Insulin associated or not with one or more oral and / or injectable antidiabetic agents (analog of GLP1...); * Benefiting from at least 1 capillary glucose per day (carried out by the patient himself or a caregiver); * Benefiting from a standardized geriatric assessment; * Signature of informed consent * Patient benefiting from a social security system. Exclusion Criteria: * Male or female aged \<75 years; * Person without diabetes or type 1 diabetes; * Patient treated only lifestyle modifications and / or oral anti-diabetic drugs and / or GLP-1 receptor agonists alone; * Subjects with secondary or corticosteroid-induced diabetes; * Refusal to participate in the study or inability to collect consent; * Patient for whom follow-up of the study procedures is impossible (glycemic record impossible or insufficient); * Patient not eligible for geriatric assessment; * Patient already participating in another study; * Patient with a severe pathology limiting his life expectancy (palliative care ...) compromising his participation in the study at the discretion of the investigator; * Patient benefiting from a safeguard of justice.